Clinical Trial

pBFS Guided rTMS Over Cognitive Control Network for ASD

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 21, 2025 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this trial is to assess the efficacy and safety of precision neuromodulation for alleviating core symptoms in patients with autism spectrum disorder (ASD) who also have intellectual or developmental delay. The neuromodulation will be administered using intermittent theta burst stimulation (iTBS) targeting the left dorsolateral prefrontal cortex (DLPFC), guided by personalized Brain Functional Sector (pBFS) technology.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-05; most recent amendment 2025-02-20.
Status change: Not Yet Recruiting → Recruiting 2025-02-20
Trial Details
NCT Number NCT06255535
Lead Sponsor Changping Laboratory
Collaborators: Xi'an TCM Hospital of Encephalopathy, Linyi Hedong Rehabilitation Hospital, Jining Medical University, Fujian Maternity and Child Health Hospital, Hebei Provincial Mental Health Center
Conditions Autism Spectrum Disorder
Enrollment 215 participants
Start Date 2024-04-01
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-21